Literature DB >> 19873436

A PROTEOLYTIC ENZYME OF SERUM: CHARACTERIZATION, ACTIVATION, AND REACTION WITH INHIBITORS.

L R Christensen1, C M Macleod.   

Abstract

1. Fibrinolysin-activated lysin factor and chloroform-activated serum protease of serum and plasma are one and the same enzyme, differing only in their mode of activation. 2. The enzyme as it normally occurs in serum or plasma is not inactive because of combination with serum inhibitor. It is present as an inactive precursor or zymogen and may be activated from this state by streptococcal fibrinolysin. 3. The activation of serum protease by streptococcal fibrinolysin is a catalytic reaction, analogous to the kinase activation of trypsinogen by enterokinase. Treatment of serum or plasma with chloroform apparently results in removal of serum inhibitor which may allow autocatalytic activation of the serum protease. 4. The serum enzyme differs from trypsin in its pH of optimum activity, in its reactions with specific protease inhibitors, and in its action on casein. 5. A revised nomenclature for the serum enzyme system is suggested which more accurately describes its properties than the terms in current use.

Entities:  

Year:  1945        PMID: 19873436      PMCID: PMC2142685          DOI: 10.1085/jgp.28.6.559

Source DB:  PubMed          Journal:  J Gen Physiol        ISSN: 0022-1295            Impact factor:   4.086


  6 in total

1.  THE COAGULATION DEFECT IN HEMOPHILIA: A COMPARISON OF THE PROTEOLYTIC ACTIVITY OF CHLOROFORM PREPARATIONS OF HEMOPHILIC AND NORMAL HUMAN PLASMA.

Authors:  H J Tagnon; C S Davidson; F H Taylor
Journal:  J Clin Invest       Date:  1943-01       Impact factor: 14.808

2.  On the antitryptic action of serum-albumin.

Authors:  S G Hedin
Journal:  J Physiol       Date:  1905-07-13       Impact factor: 5.182

3.  INHIBITION OF beta HEMOLYTIC STREPTOCOCCI FIBRINOLYSIN BY TRYPSIN INHIBITOR (ANTIPROTEASE).

Authors:  I A Mirsky
Journal:  Science       Date:  1944-09-01       Impact factor: 47.728

4.  LEUCOPROTEASE AND ANTI-LEUCOPROTEASE OF MAMMALS AND OF BIRDS.

Authors:  E L Opie; B I Barker
Journal:  J Exp Med       Date:  1907-03-14       Impact factor: 14.307

5.  THE AUTODIGESTION OF NORMAL SERUM THROUGH THE ACTION OF CERTAIN CHEMICAL AGENTS. II.

Authors:  S Yamakawa
Journal:  J Exp Med       Date:  1918-06-01       Impact factor: 14.307

6.  ENZYMES OF TUBERCULOUS TISSUE.

Authors:  E L Opie; B I Barker
Journal:  J Exp Med       Date:  1908-09-05       Impact factor: 14.307

  6 in total
  16 in total

1.  Cardiology's 10 greatest discoveries of the 20th century.

Authors:  Nirav J Mehta; Ijaz A Khan
Journal:  Tex Heart Inst J       Date:  2002

2.  IN VITRO LIQUEFACTION OF HUMAN BLOOD CLOTS BY METABOLITES OF BACILLUS SUBTILIS.

Authors:  I R SHIMI; G M IMAN; M W KELADA
Journal:  Arch Mikrobiol       Date:  1963-07-18

3.  [Enzymes affecting fibrinolysis. II. The significance of erythrocytes for fibrinolysis].

Authors:  H BAYERLE; K KAMMENHUBER
Journal:  Blut       Date:  1958-04

4.  Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects.

Authors:  Manfred Schmitt; Karin Mengele; Apostolos Gkazepis; Rudolf Napieralski; Viktor Magdolen; Ute Reuning; Nadia Harbeck
Journal:  Breast Care (Basel)       Date:  2008-10-15       Impact factor: 2.860

Review 5.  Fibrinolysis Shutdown in Trauma: Historical Review and Clinical Implications.

Authors:  Hunter B Moore; Ernest E Moore; Matthew D Neal; Forest R Sheppard; Lucy Z Kornblith; Dominik F Draxler; Mark Walsh; Robert L Medcalf; Mitch J Cohen; Bryan A Cotton; Scott G Thomas; Christine M Leeper; Barbara A Gaines; Angela Sauaia
Journal:  Anesth Analg       Date:  2019-09       Impact factor: 5.108

Review 6.  Intravenous thrombolytics for ischemic stroke.

Authors:  Andrew D Barreto
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

Review 7.  Thrombolytic therapy in acute myocardial infarction. A perspective.

Authors:  S Sherry
Journal:  Drugs       Date:  1987       Impact factor: 9.546

8.  Streptococcus pyogenes triggers activation of the human contact system by streptokinase.

Authors:  Ramona Nitzsche; Maik Rosenheinrich; Bernd Kreikemeyer; Sonja Oehmcke-Hecht
Journal:  Infect Immun       Date:  2015-08       Impact factor: 3.441

9.  A history of streptokinase use in acute myocardial infarction.

Authors:  Nikhil Sikri; Amit Bardia
Journal:  Tex Heart Inst J       Date:  2007

Review 10.  Pre-clinical studies of plasmin: superior benefit-to-risk ratio of plasmin compared to tissue plasminogen activator.

Authors:  Victor J Marder
Journal:  Thromb Res       Date:  2008-08-22       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.